deltatrials
Unknown EARLY_PHASE1 INTERVENTIONAL NCT01159899

Transplantation of Bone Marrow Stem Cells Stimulated by Proteins Scaffold to Heal Defects Articular Cartilage of the Knee

Pilot Study of A One-Step Procedure for the Use of Autologous Bone Marrow Mesenchymal Stem Cells Stimulated by Proteins Scaffold to Heal Under Arthroscopy Full-Thickness Defects Articular Cartilage and Osteoarthrosis of the Knee.

Sponsor: Michel Assor, MD

Updated 6 times since 2017 Last updated: Jan 7, 2013 Started: Jul 31, 2010 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Knee Osteoarthritis and Osteoarthritis and is currently ongoing. Michel Assor, MD leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown EARLY_PHASE1

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status EARLY_PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status EARLY_PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Unknown Status EARLY_PHASE1

    Phase: Phase 0EARLY_PHASE1

Show 1 earlier version
  1. Jan 2017 — Feb 2017 [monthly]

    Unknown Status Phase 0

    First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Michel Assor, MD
Data source: University of Marseille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations